在慢性肺异构移植功能障碍中进行抗血球蛋白治疗.
Akhilesh Ajay Padhye1, Danielle Guffey2, Andres Leon-Pena1
1Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, United States.
Frontiers in transplantation
|July 21, 2025
概括
抗胸细胞球蛋白 (ATG) 在患有慢性肺异位移植功能障碍 (CLAD) 的肺移植接受者中没有改善肺功能. 然而,ATG与改善的生存率有关,这需要在随机试验中进一步调查.
科学领域:
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
- 肺部病理学 肺部病理学
背景情况:
- 肺移植生存率有所改善,但长期结果受到慢性肺异位移植功能障碍 (CLAD) 的限制.
- CLAD是移植后第一年移植衰竭和死亡的主要驱动因素.
- 抗胸细胞球蛋白 (ATG) 是一种耐火性CLAD的治疗方法,但其有效性尚未得到充分证实.
研究的目的:
- 为了回顾评估ATG对CLAD肺移植接受者的肺功能下降的影响.
- 评估ATG对诊断为CLAD的患者死亡率的影响.
主要方法:
- 对124名被诊断患有CLAD的肺移植接受者的回顾性分析 (定义为>20%的FEV1下降).
- 使用混合效应建模,比较ATG治疗的患者和不接受ATG治疗的患者之间的FEV1下降率.
- 使用细灰竞争风险建模分析所有原因的死亡率.
主要成果:
- 在124名CLAD患者中,55人 (44%) 接受了ATG.
- 与ATG前患者或非ATG患者相比,ATG治疗没有显著改变FEV1下降率.
- 服用ATG与全因死亡风险降低有关 (亚危险比率为0.66).
结论:
- 在CLAD患者中,ATG治疗没有显示出对保持肺功能有显著的益处.
- 在这个队列中,ATG与改善的生存率有关.
- 需要进一步的前性随机研究来证实这些发现,并确定ATG在CLAD管理中的作用.
关键词:
在ATG中,ATG是ATG.这就是CLAD.在 FEV1 中,FEV1 是 FEV1.抗胸细胞环球蛋白是一种抗胸细胞环球蛋白.慢性肺部异位移植功能障碍 慢性肺部异位移植功能障碍肺功能 肺功能 肺功能更多相关视频
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.7K
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
14.5K
相关概念视频
Cell-mediated Immune Responses
73.1K
Overview
73.1K
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Pulmonary Tuberculosis I
329
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
329
